IP Library Patent Application 13270443
Patent Application
App. No. 13/270,443

PROCESSES FOR PURIFICATION OF PROTEINS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/270,443
Abstract

The invention is directed to a method for purifying a protein. The method involves providing a sample containing the protein, processing the sample through a capture chromatography resin, inactivating viruses in the sample, and processing through at least one depth filter and ion-exchange membrane.

Claims (46)

1 . A method for purifying a protein comprising:

a. providing a sample containing the protein;

b. processing the sample through a capture chromatography resin to provide a first eluate comprising the protein;

c. inactivating viruses in the first eluate to provide an inactivated eluate comprising the protein;

d. processing the inactivated eluate through at least one depth filter to provide a filtered eluate comprising the protein; and

e. processing the filtered eluate through at least one ion-exchange membrane to provide a second eluate comprising the protein.

2 . The method of claim 1 wherein the depth filtration step and the ion-exchange membrane step are provided in a filter train.

3 . The method of claim 1 wherein the capture chromatography resin is selected from the group consisting of an affinity resin, an ion exchange resin, mixed-mode resin, and a hydrophobic interaction resin.

4 . The method of claim 1 wherein the capture chromatography resin is selected from the group consisting of a protein A resin, a protein G resin, a protein A/G resin, and a protein L resin.

5 . The method of claim 1 wherein the protein is selected from the group consisting of a protein fragment, an antibody, a monoclonal antibody, an immunoglobulin, and a fusion protein.

6 . The method of claim 1 wherein the sample is a cell culture.

7 . The method of claim 1 wherein the sample is clarified prior to processing through the capture chromatography resin.

8 . The method of claim 7 wherein the sample is clarified by a clarification method selected from the group consisting of centrifugation, microfiltration, ultrafiltration, depth filtration, sterile filtration, and treatment with a detergent.

9 . The method of claim 1 wherein the viral inactivation comprises a method selected from the group consisting of treatment with acid, detergent, chemicals, nucleic acid cross-linking agents, ultraviolet light, gamma radiation, and heat.

10 . The method of claim 9 wherein viral inactivation comprises lowering the pH of the first eluate to a pH of from about 3 to about 4.

11 . The method of claim 10 wherein the first eluate is incubated for about 30 to about 90 minutes during viral inactivation.

12 . The method of claim 1 wherein the inactivated eluate is adjusted to pH 5 to 10 before depth filtration step.

13 . The method of claim 1 wherein the depth filtration step comprises filtration through at least one depth filter.

14 . The method of claim 1 wherein the depth filtration step comprises filtration through at least two depth filters arranged in series or in parallel.

15 . The method of claim 1 wherein the depth filtration step is followed by a capsule sterile filtration step.

16 . The method of claim 1 wherein the ion-exchange membrane comprises a Q membrane.

17 . The method of claim 16 wherein the Q membrane step is conducted in flow-through mode.

18 . The method of claim 1 wherein the ion-exchange membrane step is followed by a capsule sterile filtration step.

19 . The method of claim 1 wherein the inactivated eluate is processed through one depth filter and the filtered eluate is processed through the ion-exchange membrane in series.

20 . The method of claim 1 wherein the second eluate is further subjected to an additional chromatography step.

21 . The method of claim 20 wherein the additional chromatography step is selected from the group consisting of hydrophobic interaction chromatography, mixed mode chromatography, and cation exchange chromatography.

22 . The method of claim 1 wherein the second eluate is further subjected to a nanofiltration step.

23 . The method of claim 1 wherein the second eluate is further subjected to an ultrafiltration and diafiltration step.

24 . A method for purifying a protein comprising:

a. providing a sample containing the protein;

b. clarifying the sample to provide a clarified sample;

c. processing the clarified sample through a capture chromatography resin to provide a first eluate comprising the protein;

d. inactivating viruses in the first eluate to provide an inactivated eluate comprising the protein;

e. processing the inactivated eluate through at least one depth filter to provide a filtered eluate comprising the protein;

f. processing the filtered eluate through at least one ion-exchange membrane to provide a second eluate comprising the protein;

g. processing the second eluate through an additional chromatography resin to provide a third eluate comprising the protein;

h. subjecting the third eluate to nanofiltration to provide a nanofiltered eluate comprising the protein; and

i. subjecting the nanofiltered eluate to ultrafiltration and diafiltration.

25 . The method of claim 24 wherein the additional chromatography resin comprises a mixed-mode chromatography resin.

26 . The method of claim 25 , wherein the processing of the second eluate through the additional mixed-mode chromatography resin comprises one or more chromatography techniques selected from the group consisting of anion exchange, cation exchange, hydrophobic interaction, hydrophilic interaction, hydrogen bonding, pi-pi bonding, and metal affinity.

27 . The method of claim 26 wherein the processing of the second eluate through the additional mixed-mode chromatography resin comprises a combination of anion exchange and hydrophobic interaction chromatography mechanisms.

28 . The method of claim 26 wherein the mixed-mode chromatography column can be operated in flow-through or bind-elute mode.

29 . The method of claim 24 wherein the additional chromatography resin comprises a cation exchange resin.

30 . The method of claim 29 , wherein the processing of the second eluate through the additional mixed-mode chromatography resin comprises one or more chromatography techniques selected from the group consisting of anion exchange, cation exchange, hydrophobic interaction, hydrophilic interaction, hydrogen bonding, pi-pi bonding, and metal affinity.

31 . The method of claim 30 wherein the processing of the second eluate through the additional mixed-mode chromatography resin comprises a combination of anion exchange and hydrophobic interaction chromatography mechanisms.

32 . The method of claim 29 wherein the cation exchange chromatography column is operated in bind-elute mode.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECORDAL OF US APPLICATION 13/270,433; PREVIOUSLY RECORDED ON REEL 030137 FRAME 0222. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 16, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 031820/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030137/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2012
From: WANG, CHEN; HICKMAN, ROBERT K.
To: ABBOTT LABORATORIES
Reel/Frame 027558/0583 →